Immuno-PET and Targeted a-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma

Watabe, T; Kabayama, K; Naka, S; Yamamoto, R; Kaneda, K; Serada, S; Ooe, K; Toyoshima, A; Wang, Y; Haba, H; Kurimoto, K; Kobayashi, T; Shimosegawa, E; Tomiyama, N; Fukase, K; Naka, T

Watabe, T (通讯作者),Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Japan.;Watabe, T (通讯作者),Osaka Univ, Inst Radiat Sci, Suita, Japan.

JOURNAL OF NUCLEAR MEDICINE, 2023; 64 (12): 1949

Abstract

Glypican-1 (GPC1) is overexpressed in several solid cancers and is associated with tumor progression, whereas its expression is low in normal tissues.......

Full Text Link